Peregrine Pharmaceuticals (PPHM) Posts Narrower than Expected Loss of 10c/Share
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Price: $1.71 +3.01%
EPS Growth %: +69.2%
Financial Fact:
Research and development: 5.44M
Today's EPS Names:
DSX, REDF, REX, More
EPS Growth %: +69.2%
Financial Fact:
Research and development: 5.44M
Today's EPS Names:
DSX, REDF, REX, More
Trade PPHM Now!
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q4 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.07 million versus the consensus estimate of $2.64 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Booz Allen Hamilton (BAH) Tops Q4 EPS by 3c; Guides In-Line FY14 EPS
- Target Corp. (TGT) Misses Q1 Views, Issues Mixed Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
